D.E. Shaw & Co’s Cantel Medical Corporation CMD Stock Holding History

D.E. Shaw & Co’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,600	Closed	-$239K	–	4103
2018 Q3	$239K	Sell	2,600 -11,200	-81%	-$1.07M	﹤0.01%	3463
2018 Q2	$1.36M	Buy	13,800 +10,800	+360%	+$1.21M	﹤0.01%	2499
2018 Q1	$334K	Buy	+3,000	New	+$336K	﹤0.01%	3100

D.E. Shaw & Co's CMD Position: Q2 2021 in Review

D.E. Shaw & Co sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 407,352 shares — an estimated $32.5M sold.

D.E. Shaw & Co first reported a position in CMD in Q2 2016 and held it in 12 quarters. The position peaked at $32.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

D.E. Shaw & Co reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
D.E. Shaw & Co sold 407,352 Cantel Medical Corporation shares in Q2 2021, an estimated $32.5M.
D.E. Shaw & Co first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 12 quarters.
D.E. Shaw & Co's Cantel Medical Corporation position peaked at $32.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.